Close

Analyst Ratings for Corvus Pharmaceuticals (CRVS) [Neutrals]

CRVS Rating Summary

CRVS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRVS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.63 (+338.7%) * Over Last 12-Mos
Rating Score: 9.2 / 10   Percentile Rank: 90%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/9/2024 Mizuho Graig Suvannavejh New Coverage Neutral
(N/A)
3.50
(N/A)
2.00
(1.51)
-24.5% Details